文献速递糖尿病肥胖与代谢综合征

宫内暴露于妊娠期糖尿病与儿童晚期及青春期代谢组学特征的前瞻性研究

A prospective study of associations between in utero exposure to gestational diabetes mellitus and metabolomic profiles during late childhood and adolescence.
PubMed 文献 · Diabetologia · 2019-11-13

该前瞻性研究纳入592对母子(其中92例暴露于GDM),在6-14岁和12-19岁两个时间点采集代谢组学数据,采用主成分分析提取代谢物模式。结果显示GDM暴露与儿童晚期一种以磷脂酰胆碱、二酰甘油和磷脂酰乙醇胺升高为特征的代谢物模式相关,该模式在女孩中与更高的肥胖度和更差的代谢风险相关,而在男孩中无此关联。

要点

  • GDM暴露与儿童晚期「因子4」代谢物模式(磷脂类升高)的Q4相比Q1-3的OR为1.78(95%CI 1.04-3.04;p=0.04)。
  • 该代谢物模式在女孩中与随访期间更高的BMI z评分、空腹胰岛素、HOMA-IR和瘦素相关。
  • 该代谢物模式与男孩的健康结局无关。

核心结论

  • 母亲GDM暴露与儿童晚期和青春期以血清磷脂升高为特征的代谢物模式名义上相关(α=0.05)。
  • 该代谢物模式在女性子代中与整个儿童晚期至青春期过渡期间更高的肥胖度和代谢风险相关。

研究设计与样本

  • 前瞻性研究,纳入592对母子,其中92例暴露于GDM。
  • 在6-14岁(T1)和12-19岁(T2)采集非靶向代谢组学数据,并在T1和T2收集肥胖度和代谢风险生物标志物信息。
  • 通过主成分分析将T1的767种代谢物整合为因子(代谢物模式),使用多变量回归识别与GDM暴露差异相关的因子(α=0.05)。

主要发现

  • PCA保留6个因子,GDM暴露与T1时「因子4」处于Q4(对比Q1-3)的更高几率相关(OR 1.78 [95% CI 1.04, 3.04];p=0.04),该模式包含磷脂酰胆碱、二酰甘油和磷脂酰乙醇胺。
  • GDM在T1和T2均与「因子4」中部分单个化合物的升高一致相关。
  • 「因子4」每增加1单位,对应BMI z评分高0.17(0.08, 0.25)单位、空腹胰岛素高8.83(5.07, 12.59)pmol/l、HOMA-IR高0.28(0.13, 0.43)单位、瘦素高4.73(2.15, 7.31)nmol/l。
  • 该代谢物模式与男孩的健康结局无关,但在女孩中与整个随访期间更高的肥胖度和更差的代谢谱相关。

临床怎么用

  • 对于GDM母亲所生女性子代,儿童晚期至青春期应关注肥胖度和代谢风险指标的监测。
  • 血清磷脂类代谢物模式可能作为GDM暴露子代代谢风险的早期标志物,但需进一步验证。

局限性

  • GDM与代谢物模式的关联为名义上显著(α=0.05),需未来研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: This study aimed to: (1) identify metabolite patterns during late childhood that differ with respect to exposure to maternal gestational diabetes mellitus (GDM); (2) examine the persistence of GDM/metabolite associations 5 years later, during adolescence; and (3) investigate the associations of metabolite patterns with adiposity and metabolic biomarkers from childhood through adolescence. METHODS: This study included 592 mother-child pairs with information on GDM exposure (n = 92 exposed), untargeted metabolomics data at age 6-14 years (T1) and at 12-19 years (T2), and information on adiposity and metabolic risk biomarkers at T1 and T2. We first consolidated 767 metabolites at T1 into factors (metabolite patterns) via principal component analysis (PCA) and used multivariable regression to identify factors that differed by GDM exposure, at α = 0.05. We then examined associations of GDM with individual metabolites within factors of interest at T1 and T2, and investigated associations of GDM-related factors at T1 with adiposity and metabolic risk throughout T1 and T2 using mixed-effects linear regression models. RESULTS: Of the six factors retained from PCA, GDM exposure was associated with greater odds of being in quartile (Q)4 (vs Q1-3) of 'Factor 4' at T1 after accounting for age, sex, race/ethnicity, maternal smoking habits during pregnancy, Tanner stage, physical activity and total energy intake, at α = 0.05 (OR 1.78 [95% CI 1.04, 3.04]; p = 0.04). This metabolite pattern comprised phosphatidylcholines, diacylglycerols and phosphatidylethanolamines. GDM was consistently associated with elevations in a subset of individual compounds within this pattern at T1 and T2. While this metabolite pattern was not related to the health outcomes in boys, it corresponded with greater adiposity and a worse metabolic profile among girls throughout the follow-up period. Each 1-unit increment in Factor 4 corresponded with 0.17 (0.08, 0.25) units higher BMI z score, 8.83 (5.07, 12.59) pmol/l higher fasting insulin, 0.28 (0.13, 0.43) units higher HOMA-IR, and 4.73 (2.15, 7.31) nmol/l higher leptin. CONCLUSIONS/INTERPRETATION: Exposure to maternal GDM was nominally associated with a metabolite pattern characterised by elevated serum phospholipids in late childhood and adolescence at α = 0.05. This metabolite pattern was associated with greater adiposity and metabolic risk among female offspring throughout the late childhood-to-adolescence transition. Future studies are warranted to confirm our findings.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Perng W, Ringham BM, Smith HA, et al. A prospective study of associations between in utero exposure to gestational diabetes mellitus and metabolomic profiles during late childhood and adolescence. Diabetologia. 2019. PMID: 31720734. doi:10.1007/s00125-019-05036-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。